* Study director for Preclinical and Phase I-III Clinical Trials with focus in Oncology* Oversee development, fit-for-purpose validation and clinical deployment of cell-based immunoassays including Drug Receptor Occupancy, Immune-Monitoring, CAR-T cell Phenotyping, Cytokine Profiling and Phospho-flow Analysis * Responsible for data interpretation, generation and presentation of reports to sponsors and leadership,formulate recommendations for next steps* Point of contact for all study related decisions and internal and external stakeholder communications* Lead author for all study documentation including assay plans, sponsor communications and regulatory compliance (GLP/GCP/CAP/CLIA)* Collaborate with different teams to provide cross functional support and manage priorities to meet timelines and deliverables across multiple programs

* Identified functionally distinct human CD4 T cells subsets for use in Adoptive T Cell Therapy using Flow Cytometry and Genome sequencing (RNA- and ATAC-seq) techniques* Designed and executed in vitro assays to study T cell activation and function* Subject matter expert for application of cell metabolism tools to study T cell function* Published multiple peer-reviewed articles; Wrote and secured several fellowships and travel awards* Put together a training program for interns including project outlines and supervised daily operational duties

Lab of Dr. Luca Pellegrini* Maintained lab inventory and equipment, performed cost analysis and purchased supplies * Communicated with regulatory agencies to implement biosafety measures* Trained new lab members on lab and safety procedures

* Developed cell based assays to screen small molecule anti cancer drugs* Involved in developing assays for studying protein-protein interactions in cells* General lab management including ordering supplies, cell culture maintenance and preparation of SOP's